CliffBio
small molecule

PSEUDO-12

PSEUDOEPHEDRINE POLISTIREX

Loss of exclusivity—loss of exclusivity
CompanyUCB →See this company's full patent-cliff portfolio

Drug detail

Brand namePSEUDO-12
Active ingredientPSEUDOEPHEDRINE POLISTIREX
StrengthEQ 60MG HYDROCHLORIDE/5ML
Dosage formSUSPENSION, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 1987
Marketing statusDISCN

More from UCB

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PSEUDO-12 patent cliff — loss of exclusivity — | CliffBio